Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia

Walker, Zuzana; Gandolfo, Federica; Orini, Stefania; Garibotto, Valentina; Agosta, Federica; Arbizu, Javier; Bouwman, Femke; Drzezga, Alexander; Nestor, Peter; Boccardi, Marina; Altomare, Daniele; Festari, Cristina; Nobili, Flavio

doi:10.1007/s00259-018-4031-2

Scientific article

English

Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia

ContributorsWalker, Zuzana; Gandolfo, Federica; Orini, Stefania; Garibotto, Valentina

; Agosta, Federica; Arbizu, Javier; Bouwman, Femke; Drzezga, Alexander; Nestor, Peter; Boccardi, Marina; Altomare, Daniele; Festari, Cristina; Nobili, Flavio

Published inEuropean Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 9, p. 1534-1545

Publication date2018

Affiliation entities

Research groups

Citation (ISO format)

WALKER, Zuzana et al. Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia. In: European Journal of Nuclear Medicine and Molecular Imaging, 2018, vol. 45, n° 9, p. 1534–1545. doi: 10.1007/s00259-018-4031-2